Progesterone Receptor Negative Active Not Recruiting Phase 1 Trials for Epirubicin (DB00445)

IndicationStatusPhase
DBCOND0038639 (Progesterone Receptor Negative)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01624441Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast CancerTreatment